tiprankstipranks
Trending News
More News >
Akero Therapeutics (AKRO)
:AKRO
US Market
Advertisement

Akero Therapeutics (AKRO) Technical Analysis

Compare
611 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Akero Therapeutics’s (AKRO) Moving Averages Convergence Divergence (MACD) indicator is -0.78, suggesting Akero Therapeutics is a Buy.
Akero Therapeutics’s (AKRO) 20-Day exponential moving average is 48.72, while Akero Therapeutics’s (AKRO) share price is $48.19, making it a Sell.
Akero Therapeutics’s (AKRO) 50-Day exponential moving average is 49.34, while Akero Therapeutics’s (AKRO) share price is $48.19, making it a Sell.

Akero Therapeutics (AKRO) Pivot Points

Aug 29, 2025, 07:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
46.47
46.83
47.51
47.87
48.55
48.91
49.59
Fibonacci
46.83
47.23
47.47
47.87
48.27
48.51
48.91
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akero Therapeutics (AKRO) Moving Averages

Aug 29, 2025, 07:51 PM
Period
Simple
Exponential
MA5
47.90Sell
47.74Sell
MA10
48.13Sell
48.11Sell
MA20
48.81Sell
48.72Sell
MA50
50.80Sell
49.34Sell
MA100
47.62Sell
47.83Sell
MA200
42.77Buy
42.46Buy
Akero Therapeutics’s (AKRO) 10-Day exponential moving average is 48.11, while Akero Therapeutics’s (AKRO) share price is $48.19, making it a Sell.
Akero Therapeutics’s (AKRO) 100-Day exponential moving average is 47.83, while Akero Therapeutics’s (AKRO) share price is $48.19, making it a Sell.
Akero Therapeutics’s (AKRO) stock price is $48.19 and Akero Therapeutics’s (AKRO) 50-day simple moving average is 50.80, creating a Sell signal.
Akero Therapeutics’s (AKRO) stock price is $48.19 and Akero Therapeutics’s (AKRO) 100-day simple moving average is 47.62, creating a Sell signal.
Akero Therapeutics’s (AKRO) stock price is $48.19 and Akero Therapeutics’s (AKRO) 200-day simple moving average is 42.77, creating a Buy signal.

Akero Therapeutics (AKRO) Technical Indicators

Aug 29, 2025, 07:51 PM
Name
Value
Implied Action
RSI (14)
41.68
Neutral
STOCH (9,6)
39.36
Neutral
STOCHRSI (14)
36.30
Neutral
MACD (12,26)
-0.78
Buy
ADX (14)
16.61
Buy
Williams %R
-70.35
Buy
CCI (14)
-86.91
Neutral
ATR (14)
1.93
-
Ultimate Oscillator
52.37
Neutral
ROC
-6.98
Sell
Akero Therapeutics’s (AKRO) Relative Strength Index (RSI) is 41.68, creating a Neutral signal.
Akero Therapeutics’s (AKRO) Trend Strength Indicator (ADX) is 16.61, creating a Buy signal.
Akero Therapeutics’s (AKRO) Commodity Channel Index (CCI) is -86.91, creating a Neutral signal.
Akero Therapeutics’s (AKRO) Price Rate of Change (ROC) is -6.98, creating a Sell signal.

FAQ

Is AKRO a Buy, Hold, or Sell?
Based on AKRO’s technical indicators, AKRO is a Sell.
    What is AKRO’s RSI (14)?
    AKRO’s RSI (14) is 41.68, which suggests AKRO is a Neutral.
      What is AKRO’s MACD?
      AKRO’s MACD is -0.78, which suggests AKRO is a Buy.
        What is AKRO’s 5-day moving average?
        AKRO’s 5-day moving average is 47.90, which suggests AKRO is a Sell.
          What is AKRO’s 20-day moving average?
          AKRO 20-day moving average is 48.81, which suggests AKRO is a Sell.
            What is AKRO’s 50-day moving average?
            AKRO’s 50-day moving average is 50.80, which suggests AKRO is a Sell.
              What is AKRO’s 200-day moving average?
              AKRO’s 200-day moving average is 42.77, which suggests AKRO is a Buy.
                What is AKRO’s Williams % R (14)?
                AKRO’s Williams % R (14) is -70.35, which suggests AKRO is a Buy.
                  What is AKRO’s CCI (14)?
                  AKRO’s CCI (14) is -86.91, which suggests AKRO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis